
OHI Stock Forecast & Price Target
OHI Analyst Ratings
Bulls say
Omega Healthcare Investors Inc. has raised its 2025 Funds From Operations (FFO) estimate from $2.78 per share to $2.81 per share, indicating an optimistic outlook driven by higher-than-expected investment volume. Additionally, the normalized FFO estimate for 2025 has been increased to $2.95 per share from $2.89 per share, excluding non-recurring items. The company's stock performance has been robust, with a year-to-date increase of 12%, outperforming the VNQ's 4% return, while trading near the higher end of its 10-year valuation range.
Bears say
Omega Healthcare Investors Inc faces significant operator challenges that hinder a more positive outlook on the company's performance and future prospects. The company's relative valuation remains concerning despite an anticipated slight increase in adjusted funds from operations (FFO) estimates, with projections rising to $3.22 per share for 2026, above the consensus of $3.10 per share. These financial hurdles, alongside the persistent difficulties within the operational landscape, contribute to a negative sentiment regarding the stock's potential growth.
This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.
OHI Analyst Forecast & Price Prediction
Start investing in OHI
Order type
Buy in
Order amount
Est. shares
0 shares